Navigation Links
RiverGlade Capital Welcomes Jim Hudak and Dan Skowronski
Date:8/9/2018

RiverGlade Capital (“RiverGlade”), is pleased to announce that Jim Hudak has been engaged as an Operating Partner and will have an exclusive relationship with the firm. As an Operating Partner, Mr. Hudak will play a key role in the firm’s strategic planning, human capital sourcing, and deal origination, evaluation and diligence. He brings a wealth of healthcare industry knowledge and executive operating experience to RiverGlade, having spent the last six years as Chief Executive Officer of Paradigm Outcomes before moving into the Executive Chairman role in late 2017. Prior to Paradigm, Mr. Hudak was Chief Administrative Officer at CRC Health Group, where he oversaw several functions including human resources, IT, risk management and finance and spent a number of years at Accenture (formerly Andersen Consulting), ultimately becoming the Global Managing Partner of the Healthcare Practice. Additionally, he was Executive Vice President of UnitedHealth Group and Corporate Chief Information Officer and Chief Executive Officer of its subsidiary United Behavioral Health. Mr. Hudak received his Bachelor’s in economics at Yale University and a Master’s of Public Policy from the Gerald R. Ford School of Public Policy (the “Ford School”) at the University of Michigan. Mr. Hudak also chairs the Ford School Committee, which provides volunteer leadership in fundraising and reviews the goals, programs and plans of the school.

The RiverGlade investment team has added Dan Skowronski as Vice President. Mr. Skowronski has eight years of experience investing in and advising middle market companies. Prior to joining RiverGlade, Mr. Skowronski was a Senior Associate at The Edgewater Funds and prior to that was an Associate at Swander Pace Capital. During his time at Edgewater and Swander Pace, Mr. Skowronski was involved in all aspects of each firm’s investment process including deal origination and execution, debt financing and refinancing transactions, portfolio company sales, add-on acquisitions, and restructurings, as well as monitoring of portfolio companies in the healthcare, consumer and industrials sectors. Previously, he was an Investment Banking Analyst at William Blair & Company, where he executed sell-side and buy-side transactions for private equity firms, publicly-traded companies and privately-held and family-owned businesses in the consumer & retail sector. Mr. Skowronski began his career as a Financial Advisory Services Analyst at Houlihan Lokey, where he provided fairness opinions, solvency opinions and valuations for privately-held and publicly-traded companies across a variety of industries. Mr. Skowronski holds a BBA in Finance from University of Michigan’s Ross School of Business and an MBA from Northwestern University’s Kellogg School of Management.

About RiverGlade Capital
RiverGlade Capital is a healthcare services focused private equity firm that targets founder-owned, high-quality, differentiated businesses. RiverGlade partners with companies that have proven historical organic growth where value can be accelerated through human capital investments, operational improvements, strategic planning, and dynamic organic and inorganic growth initiatives. For more information, visit http://www.rivergladecapital.com.

Read the full story at https://www.prweb.com/releases/riverglade_capital_welcomes_jim_hudak_and_dan_skowronski/prweb15682630.htm.


'/>"/>
Source: PRWeb
Copyright©2018 Vocus, Inc.
All rights reserved


Related medicine news :

1. Personify Enters into Agreement to Receive Strategic Investment from Pamlico Capital
2. myStrength Raises Growth Capital to Accelerate Expansion of its Digital Behavioral Health Platform
3. MeYou Health Names New CEO, Raises New Capital, and Enters a New Market
4. G&H Orthodontics Announces Today Its Acquisition by Altaris Capital Partners, LLC
5. The Rise of “Cosmetic Surgery Capitals” Worldwide Underlines the Effectiveness of Today’s Procedures, Says Dr. J Plastic Surgery
6. Centric Bank Donates $50,000 toward The Salvation Army Harrisburg Capital City Region’s Service and Worship Center–an Oasis of Hope for Children and Families
7. TwelveStone Health Partners Announces Investment by Claritas Capital
8. GE Capital's Former Managing Director, Michael Horton, Joins StartUp Health as Chief Financial Officer
9. Provia Laboratories, cGMP Autologous Stem Cell Company, Launches $2M Growth Capital Financing Round, Engages US Capital Partners as Investment Bank
10. First National Capital Continues Strong Momentum with Office Expansion and Hiring Surge
11. First Stop Health Secures an Additional $1.6 million in Capital to Accelerate Growth
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2019)... (PRWEB) , ... June 24, 2019 , ... ... adolescents and adults, today announced the restructuring of the Strategic Advisory Board (SAB) ... to meet the demand for behavioral health care. , We are ...
(Date:6/20/2019)... ... June 20, 2019 , ... ... IT services, announced that Angel Rosa has been appointed as Senior Vice President ... developing and implementing new services, growing and nurturing high performing teams, and driving ...
(Date:6/20/2019)... ... , ... The 2019 Colorado Classic® presented by VF Corporation will showcase its ... elite teams, organizers announced today. The top-four domestic teams in USA Cycling’s Pro ... , The standalone pro women’s road race has received commitments from 16 teams, ...
(Date:6/19/2019)... ... ... CEO Steven C. Bilt of Smile Brands Inc. has won a Glassdoor ... , one of the world’s largest job and recruiting sites, released its annual report ... throughout North America and parts of Europe. , Smile Brands, a leading dental support ...
(Date:6/19/2019)... ... June 19, 2019 , ... The FSH Society announced ... in Marseille, France. The conference is widely seen as the premier global platform ... Nearly 200 researchers, clinicians, industry representatives and patient advocates are attending. , Researchers ...
Breaking Medicine News(10 mins):
(Date:6/20/2019)... NEW YORK (PRWEB) , ... June 20, 2019 ... ... showed signs that exposure to dust from the World Trade Center site had ... according to a study by Mount Sinai researchers in Molecular Cancer Research in ...
(Date:6/20/2019)... ... June 20, 2019 , ... ... clinical trials, today announced its scientific and technological experts will present a series ... Information Association (DIA) Annual Meeting in San Diego, June 23-27. , ERT’s ...
(Date:6/20/2019)... N.C. (PRWEB) , ... June 20, 2019 , ... ... (SCTM) demonstrates how preconditioning mesenchymal stem cells (MSCs) enhances their ability to treat ... to developing more effective MSC treatments for clinical application, according to Ben Antebi, ...
Breaking Medicine Technology: